Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
American Transplant Congress 2007
Calcineurin Inhibitor and Steroid Regimens: Update on Sparing or Avoidance in High and Low-risk Transplant Recipients
San Francisco, California / May 5-9, 2007
Editorial Overview: Dana Baran, MD, FRCPC Medical Director, Quebec-Transplant Division of Nephrology MUHC-Royal Victoria Hospital Associate Professor of Medicine, McGill University Montreal, Quebec
33rd Annual Meeting of the European Group for Blood and Marrow Transplantation
Targeted Therapy in Lymphoid Malignancies: The Changing Face of Transplantation
Lyon, France / March 25-28, 2007
Lyon - Treatment of non-Hodgkin’s lymphoma generally involves chemotherapy. Autologous or allogeneic stem cell transplantation is often considered in patients who are refractory to chemotherapy. Despite intensive research in previous...
33rd Annual Meeting of the European Group for Blood and Marrow Transplantation
Update on Antifungal Treatment Strategies in Stem Cell Transplantation
Lyon, France / March 25-28, 2007
Invasive aspergillosis is a major problem in the management of patients who have undergone stem cell transplantation (SCT). According to figures presented by Prof. Noel Milpied, University Hospital, Bordeaux, France, the incidence of these...
12th Annual Update on Cardiopulmonary Bypass
Transfusion Medicine in Cardiac Surgery: Towards Implementation of a Blood Conservation Program
Whistler, British Columbia / March 18-23, 2007
Whistler - There is an urgent need to minimize the use of all blood products in cardiac surgery, speakers here agreed, not only because blood is increasingly scarce and costly, but because transfusion itself is also associated with...
Canadian Society of Transplantation Annual Meeting
Balancing Efficacy and Toxicity: Best Practice Immunosuppressive Strategies
Banff, Alberta / March 15-18, 2007
Regardless of the organ being transplanted, the primary goal of post-transplantation management is to balance effective immunosuppression and avoidance of rejection on the one hand and minimize toxicity, especially long-term toxicity to the...
43rd European Renal Association/European Dialysis and Transplant Association Congress
Setting the Stage for Improved Chronic Kidney Disease Outcomes
Glasgow, United Kingdom / July 15-18, 2006
Glasgow - The annual mortality rate for patients on dialysis in Canada is approximately 15%. It is now known that treating chronic kidney disease patients on dialysis with calcium-based phosphate binders can lead to cardiac calcification....
43rd Congress of the European Renal Association/European Dialysis and Transplant Association
Controlling Phosphorus Levels and Improving Compliance in Dialysis Patients
Glasgow, United Kingdom / July 15-18, 2006
Glasgow - When undergoing hemodialysis, almost all patients develop elevated serum phosphorus levels and require a phosphate-binding agent to keep levels under control. While both calcium-containing phosphate binders and sevelamer, a...
10th Conference of the Canadian Blood and Marrow Transplant Group
CML Standard of Care: Reviewing the Updated Recommendations
Edmonton, Alberta / April 21-24, 2006
Edmonton - In patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML), the tyrosine kinase inhibitior (TKI) imatinib has become the gold standard of therapy. Long-term results from IRIS (International Randomized Trial...
10th Biennial Meeting of the Canadian Blood and Marrow Transplant Group
Expanding Therapeutic Options for Chronic Myeloid Leukemia
Edmonton, Alberta / April 21-24, 2006
Edmonton - The arrival of imatinib as a targeted therapeutic option for chronic myeloid leukemia (CML) has been a highly encouraging development for the prognosis for this disease, and for patients who achieve a good early response to...